Jonathan Kimmelman
KimmelmanJ
Cool study, 'Inferences about drug safety in phase 3 trials in oncology: Examples from advanced prostate cancer' in @JNCI_Now from @JoshDragoMD @gonen_mithat et al 1/https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/dja
Read more
If you participate in a #cancer phase 1 trial, what are the chances of receiving a drug, at the right dose, that will eventually be approved for your cancer? About
Read more